Glycom Manufacturing A/S
Public limited companyCVR 37207713Esbjerg NActive
Glycom Manufacturing A/S is a public limited company, based in Esbjerg N, active in manufacture of basic pharmaceutical products, founded in 2015. Net profit rose 4514% from 2024 to 2025, ending at DKK 69.2m. Measured by gross profit, it ranks no. 2 of 14 companies in the industry in the database. With 116 employees, the company is about 6 times larger than the industry median.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesFinancials: 2025 against 2024
- Gross profit rose 67% (2024 → 2025), to DKK 226.3m.
- Net profit rose 4,514% (2024 → 2025), to DKK 69.2m.
- Equity rose 14% (2024 → 2025), to DKK 577.7m.
Employees
- 20 more employees than a year earlier: 116 (07/2026) against 96 (07/2025).
Management and owners, last 24 months
- New in management: Michel Wilhelm Léon Meertens (board member, 29/01/2025), Kjeld Raunkjær Kjeldsen (ceo, 07/05/2025) and Gernot Stadlmann (board member, 07/05/2025).
- Stepped down: Hervé Geoffrey Hartmann (ceo, 30/04/2025), Hervé Geoffrey Hartmann (board member, 30/04/2025) and Robert David Ellis (chair of the board, 29/01/2025).
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2020–2025 · amounts in DKK thousandEquity and net profit
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change | |
|---|---|---|---|---|---|---|---|
| Revenue | not stated | not stated | not stated | not stated | not stated | not stated | – |
| Gross profit | 168,693 | 208,378 | 116,734 | 170,409 | 135,830 | 226,265 | +66.6% |
| Operating profit (EBIT) | 41,157 | 66,049 | −28,958 | 20,155 | 9,302 | 93,319 | +903.2% |
| Profit before tax | 31,595 | 62,891 | −32,308 | 13,805 | 3,578 | 90,252 | +2,422.4% |
| Net profit | 31,248 | 49,033 | −27,129 | 13,673 | 1,500 | 69,205 | +4,513.7% |
| Total assets | 881,097 | 756,683 | 764,559 | 811,359 | 669,858 | 813,618 | +21.5% |
| Equity | 471,417 | 520,450 | 493,321 | 506,994 | 508,494 | 577,699 | +13.6% |
| Liabilities | – | 212,924 | 246,437 | 282,811 | 139,810 | 235,919 | +68.7% |
| Cash and cash equivalents | 3,183 | 2,368 | 7,018 | 15,658 | 9,361 | 1,680 | −82.1% |
| Average number of employees | 97 | 98 | 101 | 108 | 83 | 94 | +13.3% |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Annual reports
6 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 01/01/2025 – 31/12/2025 | 30/06/2026 | The company | PDF not statedXBRL |
| 2024 | 01/01/2024 – 31/12/2024 | 16/07/2025 | The company | PDFXBRL |
| 2023 | 01/01/2023 – 31/12/2023 | 28/07/2024 | The company | PDFXBRL |
| 2022 | 01/01/2022 – 31/12/2022 | 05/07/2023 | The company | PDFXBRL |
| 2021 | 01/01/2021 – 31/12/2021 | 12/07/2022 | The company | PDFXBRL |
| 2020 | 01/01/2020 – 31/12/2020 | 06/07/2021 | The company | PDFXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
14 companies in the databaseComparison with the other companies in manufacture of basic pharmaceutical products based on the latest financial year.
Industry median: gross profit DKK 13.9m, net profit DKK 80,789, equity DKK 10.1m, 19 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with 50–199 employees4,467 companies in the comparison | No. 148of 4,412 Better than 97% | No. 132of 4,466 Better than 97% |
| Companies that are between 5 and 14 years old33,688 companies in the comparison | No. 141of 33,588 Better than 100% | No. 157of 33,687 Better than 100% |
| All companies of type A/S18,025 companies in the comparison | No. 687of 17,786 Better than 96% | No. 626of 18,024 Better than 97% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Manufacture of basic pharmaceutical products- Glycom Manufacturing A/SDKK 226.3m
- Xellia Pharmaceuticals ApSDKK 314.9m
- Biofac A/SDKK 73.6m
- Glycom Manufacturing A/SDKK 69.2m
- Xellia Pharmaceuticals ApSDKK 213.7m
- Biofac A/S−DKK 3.8m
- Glycom Manufacturing A/SDKK 577.7m
- Xellia Pharmaceuticals ApSDKK 404.6m
- Biofac A/SDKK 10.8m
- Glycom Manufacturing A/S116
- Xellia Pharmaceuticals ApS458
- Biofac A/S83
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership RegisterManagement
4 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Kjeld Raunkjær Kjeldsen | CEO | 07/05/2025 |
Board of directors
| Name | Role | Appointed |
|---|---|---|
| Kjeld Raunkjær Kjeldsen | Board member | 26/08/2022 |
| Michel Wilhelm Léon Meertens | Board member | 29/01/2025 |
| Gernot Stadlmann | Board member | 07/05/2025 |
- Founders
- KR 332 ApS
Former management (20)
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| Christina Bruun Geertsen | Board member | 05/11/2015 | 20/12/2015 |
| Bent Kemplar | Director | 05/11/2015 | 20/12/2015 |
| Bent Kemplar | Board member | 05/11/2015 | 20/12/2015 |
| Jeppe Buskov | Chair of the board | 05/11/2015 | 20/12/2015 |
| Niels Axel Stokholm Banke | Board member | 20/12/2015 | 02/09/2020 |
| John Brett Theroux | Chair of the board | 20/12/2015 | 02/05/2019 |
| Jesper Mørk | CEO | 20/12/2015 | 26/08/2022 |
| Jesper Mørk | Board member | 20/12/2015 | 26/08/2022 |
| Kjeld Raunkjær Kjeldsen | Board member | 26/04/2016 | 02/09/2020 |
| Odd Erik Hansen | Board member | 26/04/2016 | 01/05/2019 |
| Thomas Troelsgaard Kabel | Board member | 26/04/2016 | 02/05/2019 |
| Odd Erik Hansen | Chair of the board | 02/05/2019 | 04/03/2021 |
| Carsten Gram Andersen | Board member | 02/05/2019 | 02/09/2020 |
| Joseph Maria Antonius Arets | Board member | 02/09/2020 | 03/03/2021 |
| Luca Rosetto | Board member | 02/09/2020 | 04/03/2021 |
| Anders Glargaard | Board member | 04/03/2021 | 26/08/2022 |
| Joseph Maria Antonius Arets | Chair of the board | 04/03/2021 | 26/08/2022 |
| Hervé Geoffrey Hartmann | CEO | 26/08/2022 | 30/04/2025 |
| Hervé Geoffrey Hartmann | Board member | 26/08/2022 | 30/04/2025 |
| Robert David Ellis | Chair of the board | 26/08/2022 | 29/01/2025 |
Signing rule: Selskabet tegnes af 2 bestyrelsesmedlemmer i forening eller af 1 bestyrelsesmedlem og 1 direktør i forening.
Address and production units
1 active production unitsLimfjordsvej 4
6715 Esbjerg N
| Production unit | Address | Employees | P number |
|---|---|---|---|
| Glycom Manufacturing A/S | Limfjordsvej 4, 6715 Esbjerg N | 122 | 1020872639 |
Purpose
Selskabets formål er at drive virksomhed inden for udvikling og fremstilling af samt handel med biomolekyler til den farmaceutiske industri og ernæringsindustrien.
The purpose is quoted from the register in Danish.
Changes year by year
64 registered events20261 changeaccounts 1
- AccountsAnnual report for 2025 published
20257 changesaccounts 1 · management 6
- AccountsAnnual report for 2024 published
- ManagementGernot Stadlmann appointed board member
- ManagementKjeld Raunkjær Kjeldsen appointed ceo
- ManagementHervé Geoffrey Hartmann stepped down as board member
- ManagementHervé Geoffrey Hartmann stepped down as ceo
- ManagementMichel Wilhelm Léon Meertens appointed board member
- ManagementRobert David Ellis stepped down as chair of the board
20241 changeaccounts 1
- AccountsAnnual report for 2023 published
20231 changeaccounts 1
- AccountsAnnual report for 2022 published
20229 changesmanagement 8 · accounts 1
- ManagementRobert David Ellis appointed chair of the board
- ManagementKjeld Raunkjær Kjeldsen appointed board member
- ManagementHervé Geoffrey Hartmann appointed board member
- ManagementHervé Geoffrey Hartmann appointed ceo
- ManagementJoseph Maria Antonius Arets stepped down as chair of the board
- ManagementAnders Glargaard stepped down as board member
- ManagementJesper Mørk stepped down as board member
- ManagementJesper Mørk stepped down as ceo
- AccountsAnnual report for 2021 published
20216 changesaccounts 1 · management 5
- AccountsAnnual report for 2020 published
- ManagementJoseph Maria Antonius Arets appointed chair of the board
- ManagementAnders Glargaard appointed board member
- ManagementLuca Rosetto stepped down as board member
- ManagementOdd Erik Hansen stepped down as chair of the board
- ManagementJoseph Maria Antonius Arets stepped down as board member
20205 changesmanagement 5
- ManagementLuca Rosetto appointed board member
- ManagementJoseph Maria Antonius Arets appointed board member
- ManagementCarsten Gram Andersen stepped down as board member
- ManagementKjeld Raunkjær Kjeldsen stepped down as board member
- ManagementNiels Axel Stokholm Banke stepped down as board member
20195 changesmanagement 5
- ManagementCarsten Gram Andersen appointed board member
- ManagementOdd Erik Hansen appointed chair of the board
- ManagementThomas Troelsgaard Kabel stepped down as board member
- ManagementJohn Brett Theroux stepped down as chair of the board
- ManagementOdd Erik Hansen stepped down as board member
20182 changescapital 1 · industry 1
- CapitalShare capital changed from 111,515,543 DKK to 111,515,544 DKK
- IndustryIndustry changed to Manufacture of basic pharmaceutical products (211000)
20174 changescapital 4
- CapitalShare capital changed from 111,515,542 DKK to 111,515,543 DKK
- CapitalShare capital changed from 111,515,541 DKK to 111,515,542 DKK
- CapitalShare capital changed from 111,515,540 DKK to 111,515,541 DKK
- CapitalShare capital changed from 74,350,040 DKK to 111,515,540 DKK
20165 changesmanagement 3 · address 1 · capital 1
- ManagementKjeld Raunkjær Kjeldsen appointed board member
- ManagementThomas Troelsgaard Kabel appointed board member
- ManagementOdd Erik Hansen appointed board member
- AddressMoved to Limfjordsvej 4, 6715 Esbjerg N
- CapitalShare capital changed from 500,000 DKK to 74,350,040 DKK
201518 changesname 1 · address 1 · management 12 · ownership 3 · founded 1
- NameName changed from KR 599 A/S to Glycom Manufacturing A/S
- AddressMoved to Diplomvej 373, 1. ø, 2800 Kgs. Lyngby
- ManagementNiels Axel Stokholm Banke appointed board member
- ManagementJesper Mørk appointed board member
- ManagementJesper Mørk appointed ceo
- ManagementJohn Brett Theroux appointed chair of the board
- ManagementBent Kemplar stepped down as director
- ManagementJeppe Buskov stepped down as chair of the board
- ManagementBent Kemplar stepped down as board member
- ManagementChristina Bruun Geertsen stepped down as board member
- OwnershipGLYCOM A/S registered as owner (100%)
- OwnershipKR 332 ApS is no longer registered as owner
- FoundedRegistered as KR 599 A/S
- ManagementBent Kemplar appointed director
- ManagementJeppe Buskov appointed chair of the board
- ManagementBent Kemplar appointed board member
- ManagementChristina Bruun Geertsen appointed board member
- OwnershipKR 332 ApS registered as owner (100%)
Related companies
Same people in management
- Novozymes A/Svia Niels Axel Stokholm Banke
- Bygma A/Svia Christina Bruun Geertsen
- Kromann Reumert Advokatpartnerselskabvia Bent Kemplar
- Altrad Services A/Svia Bent Kemplar
- Knorr-Bremse Rail Systems Denmark ApSvia Bent Kemplar
- SAS Connect Crew Services A/Svia Bent Kemplar
Largest in the industry
- Xellia Pharmaceuticals ApSDKK 314.9m
- Biofac A/SDKK 73.6m
- Zpd A/SDKK 52.7m
- Danipharm A/SDKK 37.6m
- Pharma Medico ApSDKK 32.3m
- A/S Orthana Kemisk FabrikDKK 20.9m
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026.